BeStock  
Stocks › Medical Devices › NVCR

Novocure NVCR

US equityMarket cap rank #3014Medical Devices
$10.71 +$0.02 (+0.19%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $10.71 0.00%
Open$10.61
Prev close$10.69
Day range$10.61 – $11.06
Volume1.64M
Market cap$1.25B
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±10.1%last 16 reports
Closed higher6 of 1638% of the time
Best reaction+28.4%
Worst reaction-24.0%

Stock move on the day after each report

-2.4%2023/Q4+11.4%2024/Q1-0.7%2024/Q2+0.6%2024/Q3-12.4%2024/Q4+4.4%2025/Q1-24.0%2025/Q2-4.9%2025/Q3-8.3%2025/Q4+27.5%2026/Q1+28.4%2026/Q2-7.5%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q329 Oct 2026Pre Market±17.7%-7.48%Within range
2026/Q223 Jul 2026Pre Market±16.1%+28.39%Bigger than priced
2026/Q130 Apr 2026Pre Market±20.6%+27.49%Bigger than priced
2025/Q426 Feb 2026Pre Market±18.7%-8.27%Within range
2025/Q330 Oct 2025Pre Market±13.1%-4.90%Within range
2025/Q224 Jul 2025Pre Market±14.1%-24.05%Bigger than priced
2025/Q124 Apr 2025Pre Market±20.5%+4.39%Within range
2024/Q427 Feb 2025Pre Market±13.2%-12.43%Within range
2024/Q330 Oct 2024Pre Market±15.8%+0.59%Within range
2024/Q225 Jul 2024Pre Market±16.1%-0.75%Within range
2024/Q12 May 2024Pre Market±16.0%+11.38%Within range
2023/Q422 Feb 2024Pre Market±20.7%-2.43%Within range
2023/Q326 Oct 2023Pre Market±21.9%-7.53%Within range
2023/Q227 Jul 2023Pre Market±15.6%-15.89%Bigger than priced
2023/Q14 May 2023Pre Market±12.2%+1.21%Within range
2022/Q423 Feb 2023Pre Market±13.2%-4.54%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2025/FY

By region

  • United States$385.63M 58.8%
  • Germany$79.41M 12.1%
  • France$76.19M 11.6%
  • Other international markets$56.90M 8.7%
  • Japan$37.79M 5.8%
  • Greater China$19.44M 3.0%

Latest reported quarter: Q3, ended Sep 2026

Revenue$193.40M+15.7% YoY
Operating profit-$6.17M+82.9% YoY
Net profit-$10.44M+72.0% YoY
Diluted EPS-$0.09+72.7% YoY
Free cash flow$15.75M+5.5% YoY
Operating cash flow$22.67M

Revenue, last 8 quarters

$161.3MDec '24$155.0MMar '25$158.8MJun '25$167.2MSep '25$174.4MDec '25$174.1MMar '26$183.6MJun '26$193.4MSep '26

Net profit, last 8 quarters

$-65.9MDec '24$-34.3MMar '25$-40.1MJun '25$-37.3MSep '25$-24.5MDec '25$-71.1MMar '26$-15.7MJun '26$-10.4MSep '26

Profitability & balance sheet

Gross margin77.0%
Operating margin-17.2%
Net margin-16.8%
Return on equity-35.2%
Return on assets-11.1%
Return on invested capital-14.1%
Current ratio2.49
Liabilities / assets57.7%
Cash & investments$463.48M
Total debt$231.55M
Net cash (debt)$231.93M

Discussion

No comments yet — be the first to weigh in on NVCR.

Sign in to join the discussion.

Scroll to Top